Pharmaceutical eConsulting (PeC) is investing to remain the chosen partner for electronic regulatory submissions services. Today, the company announced the addition of Shylendra Kumar as Senior Principal Consultant. In this role, Mr. Kumar will contribute, together with Yolanda Hall, to the establishment of innovative consulting services for the life science industry, developing strategies and plans to execute the US business.Mr. Kumar brings more than 18 years of experience in developing and delivering innovative solutions for the life sciences industry. Prior to joining PeC, he served as President and CEO of Datafarm, Inc., which was one of the leading solutions providers for the life sciences industry. Kumar is an accomplished senior-level executive with expertise in building and managing high-performing teams. He is an innovative thinker with solutions-oriented approach to organize and develop systems and processes in order to drive organizational stability, growth and profitability. Kumar has practical hands-on experience in many aspects of drug development processes, with domain expertise in Regulatory Electronic Submissions and Clinical Data.Steen Otto Rugaard, CEO and founder at PeC A/S states "Shy was instrumental in creating, selling, and implementing electronic submission solutions for the life sciences industry and this experience gives him the unique ability to provide exceptional leadership and create a culture of high achievement and excellent customer service, while contributing to the overall management and strategic development of our company. Plus, he is one of the best and brightest in the industry, so I am personally thrilled to have him on the PeC team.""The speed at which PeC has become one of the leading electronic submission services providers in Europe is staggering," said Shy Kumar. "I look forward at the opportunity to extend such unprecedented market leadership world-wide."
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment